Chris Medlar is a dynamic National Sales Director at SUN PHARMA, where he spearheads an Oncology Field Based team comprising six Directors and 24 Account Managers. With a robust background in oncology, rare diseases, and hematology, Chris has established himself as a pivotal figure in...
Chris Medlar is a dynamic National Sales Director at SUN PHARMA, where he spearheads an Oncology Field Based team comprising six Directors and 24 Account Managers. With a robust background in oncology, rare diseases, and hematology, Chris has established himself as a pivotal figure in the pharmaceutical industry, particularly in the launch and commercialization of innovative therapies. His enterprising mindset is reflected in his ability to architect effective field sales structures and develop comprehensive competency models that drive sales effectiveness across diverse therapeutic areas, including neurology and cardiology.
Under Chris's leadership, the team has successfully executed strategic plans that align with SUN PHARMA's mission to deliver cutting-edge treatments to patients. He is particularly adept at fostering cross-functional team leadership, ensuring that sales initiatives are seamlessly integrated with marketing and medical affairs to optimize product launch strategies. His commitment to building successful start-up teams has resulted in significant market penetration and revenue growth in highly competitive oncology and rare disease segments.
Chris’s expertise extends beyond traditional sales tactics; he emphasizes the importance of relationship-building with healthcare professionals and stakeholders, which is crucial in navigating the complexities of hospital sales and specialty pharmacy channels. His strategic vision and hands-on approach have not only enhanced the performance of his team but have also contributed to the overall success of SUN PHARMA’s oncology portfolio, solidifying his reputation as a leader who is dedicated to making a lasting impact in the pharmaceutical landscape.
